Quest Diagnostics Incorporated Stock

Equities

DGX

US74834L1008

Healthcare Facilities & Services

Market Closed - Nyse 04:00:02 2024-04-22 pm EDT 5-day change 1st Jan Change
130.1 USD +1.28% Intraday chart for Quest Diagnostics Incorporated +1.13% -5.65%
Sales 2024 * 9.4B Sales 2025 * 9.72B Capitalization 14.26B
Net income 2024 * 897M Net income 2025 * 965M EV / Sales 2024 * 1.92 x
Net Debt 2024 * 3.77B Net Debt 2025 * 3.15B EV / Sales 2025 * 1.79 x
P/E ratio 2024 *
16.5 x
P/E ratio 2025 *
15.1 x
Employees 44,000
Yield 2024 *
2.25%
Yield 2025 *
2.32%
Free-Float 68.24%
More Fundamentals * Assessed data
Dynamic Chart
Quest Diagnostics Launches New Test to Help Assess Alzheimer's Disease Risk MT
John Chevedden Files an Exempt Solicitation Statement with Securities and Exchange Commission CI
Quest Diagnostics Receives Shareholder Proposal from John Chevedden CI
Quest Collaborating With Broad Clinical Labs to Assess Whole Genome Sequencing Test for Developmental Delay Disorders MT
Quest Diagnostics Receives Shareholder Proposal from John Chevedden CI
Transcript : Quest Diagnostics Incorporated Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-13-2024 10:15 AM
Quest Diagnostics Insider Sold Shares Worth $852,769, According to a Recent SEC Filing MT
Leerink Partners Starts Quest Diagnostics With Market Perform Rating, $135 Price Target MT
Quest Diagnostics Incorporated acquired Assets from Lenco Diagnostic Laboratories Inc. for approximately $110 million. CI
Quest Diagnostics' Pack Health, Instacart to Combine Grocery Delivery With Nutrition Coaching Services MT
The fate of the market depends on this Our Logo
ANALYST RECOMMENDATIONS : Airbnb, Conagra Brands, Berkshire Hathaway, Meta Platforms, Unilever.... Our Logo
Correction: Quest Diagnostics Participates in Freenome's $254 Million Financing MT
Quest Diagnostics Participates in Freenome's $254 Million Financing MT
Freenome Holdings, Inc. announced that it has received $254 million in funding from a group of investors CI
More news
1 day+1.28%
1 week+1.13%
Current month-2.27%
1 month+0.61%
3 months-0.47%
6 months+7.11%
Current year-5.65%
More quotes
1 week
125.42
Extreme 125.42
131.21
1 month
125.42
Extreme 125.42
135.45
Current year
123.04
Extreme 123.04
143.63
1 year
119.59
Extreme 119.59
148.62
3 years
119.59
Extreme 119.59
174.16
5 years
73.02
Extreme 73.02
174.16
10 years
54.90
Extreme 54.9
174.16
More quotes
Managers TitleAgeSince
Chief Executive Officer 61 13-03-31
Director of Finance/CFO 54 22-07-10
Compliance Officer - -
Members of the board TitleAgeSince
Director/Board Member 70 19-02-17
Director/Board Member 67 11-12-06
Director/Board Member 80 96-12-31
More insiders
Date Price Change Volume
24-04-22 130.1 +1.28% 1,693,434
24-04-19 128.4 +2.01% 1,557,641
24-04-18 125.9 -0.84% 873,688
24-04-17 127 -0.35% 886,750
24-04-16 127.4 -0.95% 692,266

Delayed Quote Nyse, April 22, 2024 at 04:00 pm EDT

More quotes
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows: - testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services; - other (2.7%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
128.4 USD
Average target price
142.3 USD
Spread / Average Target
+10.78%
Consensus